30 results on '"Xin, Zhixiang"'
Search Results
2. Epididymal RNase T2 contributes to astheno-teratozoospermia and intergenerational metabolic disorder through epididymosome-sperm interaction
3. ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers
4. Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer
5. Efficacy of Neoadjuvant Chemohormonal Therapy in Oligometastatic Hormone-Sensitive Prostate Cancer: A Prospective, Three-Arm, Comparative Propensity Score Match Analysis
6. SUMOylation controls the binding of hexokinase 2 to mitochondria and protects against prostate cancer tumorigenesis
7. Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy
8. Prostate transitional zone volume-based nomogram for predicting prostate cancer and high progression prostate cancer in a real-world population
9. Beneficial effect of PEDF-transfected ADSCs on erectile dysfunction in a streptozotocin-diabetic rat model
10. Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
11. Combination of the NRF2 Inhibitor and Autophagy Inhibitor Significantly Inhibited Tumorigenicity of Castration-Resistant Prostate Cancer
12. Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy‐naive metastatic castration‐resistant prostate cancer
13. Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy
14. Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination
15. Dual Targeting of Endoplasmic Reticulum by Redox-Deubiquitination Regulation for Cancer Therapy
16. Surface-enhanced Raman spectroscopy of serum predicts sensitivity to docetaxel-based chemotherapy in patients with metastatic castration-resistant prostate cancer
17. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications
18. A novel mouse model for liver metastasis of prostate cancer reveals dynamic tumour‐immune cell communication
19. PD59-01 INSM1 IS A DRIVER OF NEUROENDOCRINE PROSTATE CANCER
20. Astragalus Polysaccharide Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Damage and Mitochondrial Dysfunction
21. Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy
22. Insulinoma-associated protein 1 is a novel sensitive and specific marker for small cell carcinoma of the prostate
23. Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone
24. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer
25. Serum Pre-Albumin Predicts the Clinical Outcome in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone
26. Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome
27. Addition of Antimuscarinics to Alpha-blockers for Treatment of Lower Urinary Tract Symptoms in Men: A Meta-analysis
28. Intestinal metaplasia of the bladder in 89 patients: a study with emphasis on long-term outcome.
29. Correlation of VEGF and EGFR in peripheral blood with clinical stage and pathological grade of renal cell carcinoma and analysis of prognosis.
30. Transcriptome analysis of primary aldosteronism in adrenal glands and controls.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.